In summary, this gene panel offers a reliable method for estimating the number of breast cancer cells mixed with bone marrow cells, with EGFR and EpCAM standing out as the most promising candidates due to their superior specificity and expression levels (Fig 1A). The gene discussed is EGFR; the disease is breast carcinoma.